Patients must qualify for customized medication.Dosing may be different.Compounded medications have not been approved by the FDA; have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. FDA- approved medicines containing semaglutide or tirzepatide are available.
Stay up to date with the latest news, research, and insights from the GLP-1 community.